This document is available in three formats: this web page (for browsing content), PDF (comparable to original document formatting), and WordPerfect.  To view the PDF you will need Acrobat Reader, which may be downloaded from the Adobe site.  For an official signed copy, please contact the Antitrust Documents Group.

View the related case filings

U.S. Department of Justice Seal and Letterhead
FOR IMMEDIATE RELEASE
THURSDAY, OCTOBER 11, 2001 
WWW.USDOJ.GOV/ATR
AT
(202) 616-2777
TDD (202) 514-1888


HEARST CORPORATION TO PAY $4 MILLION CIVIL PENALTY FOR VIOLATING
ANTITRUST PRE-MERGER NOTIFICATION REQUIREMENTS

Largest Civil Penalty a Company Has Paid for Violating Antitrust Pre-Merger Requirements

WASHINGTON, D.C. -- The Hearst Corporation and its parent, The Hearst Trust, have agreed to pay $4 million to settle charges that the company failed to produce key documents before undertaking an acquisition subject to pre-merger review, the Department of Justice announced today. The civil penalty is the largest a company has ever paid for violating antitrust pre-merger requirements.

The Department of Justice's Antitrust Division, at the request of the Federal Trade Commission, filed a civil lawsuit today in U.S. District Court in Washington, D.C. against The Hearst Corporation and The Hearst Trust for violating the Hart-Scott-Rodino Act of 1976. At the same time, the Department filed a proposed settlement, that if approved by the court, will settle the charges.

According to the complaint, Hearst violated pre-merger notification requirements when it acquired Medi-Span Inc., an Indiana-based producer of integratable drug data files, in 1998 without submitting to the antitrust enforcement agencies documents required to have been supplied along with its pre-merger notification.

The Federal Trade Commission in April 2001 challenged Hearst's acquisition of Medi-Span in an antitrust lawsuit brought in U.S. District Court in Washington, D.C. That suit, which is pending, charges that combining Hearst's First DataBank subsidiary with Medi-Span gave Hearst a monopoly over a significant type of drug information database used by pharmacists, other health care professionals, hospitals and health plans.

The Hart-Scott-Rodino Act of 1976 imposes notification and waiting period requirements on individuals and companies over a certain size before they can consummate acquisitions of stock or assets over a certain value. Parties are subject to a maximum penalty of $11,000 a day for each day they are in violation of the HSR Act.

###

01-523